Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.37
-0.13 (-2.00%)
At close: Jun 27, 2025, 4:00 PM
6.38
+0.01 (0.16%)
After-hours: Jun 27, 2025, 7:55 PM EDT
Novavax Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Novavax stock ranges from a low of $6.00 to a high of $26. The average analyst price target of $16.6 forecasts a 160.60% increase in the stock price over the next year.
Price Target: $16.60 (+160.60%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novavax stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 6 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Sell Initiates $6 | Strong Sell | Initiates | $6 | -5.81% | Jun 17, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $9 → $7 | Sell | Maintains | $9 → $7 | +9.89% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +198.27% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +198.27% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +198.27% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
1.07B
from 682.16M
Increased by 56.85%
Revenue Next Year
536.05M
from 1.07B
Decreased by -49.90%
EPS This Year
2.63
from -1.23
EPS Next Year
0.32
from 2.63
Decreased by -87.85%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.3B | 1.0B | 416.9M | ||
| Avg | 1.1B | 536.1M | 292.4M | ||
| Low | 820.1M | 314.2M | 161.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 94.1% | -2.2% | -22.2% | ||
| Avg | 56.9% | -49.9% | -45.5% | ||
| Low | 20.2% | -70.6% | -69.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.72 | 2.82 | 0.33 | ||
| Avg | 2.63 | 0.32 | -0.32 | ||
| Low | 1.17 | -1.27 | -0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 7.4% | 1.8% | ||
| Avg | - | -87.8% | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.